Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Myeloid Neoplasms with t(12;22)(p13;q12) and MN1 Ectopia Are Refractory to Chemotherapy and Can Benefit from Hematopoietic Stem Cell Transplantation

Tong Wang, Xue Chen, MD, Shuang Hui, Jingbo Ni, Ying Yin, Wei Cao, Yan Zhang, Xinyu Wang, Xiaoli Ma, Panxiang Cao, Mingyue Liu, Kylan N. Chen, Fang Wang, MD, Yang Zhang, MD, Daijing Nie, MD, Lili Yuan, Hongxing Liu

Blood (2019) 134 (Supplement_1): 2721.

https://doi.org/10.1182/blood-2019-131610

Published: 2019

Journal Articles

SWI/SNF Dysregulation through a Prion-like Domain Causes AML

Simone S Riedel, PhD, Alexandra Lenard, BS, Kevin Nestler, BS, Congcong Lu, PhD, Hongbo Xie, PhD, Benjamin A Garcia, PhD, Kathrin M. Bernt, MD

Blood (2019) 134 (Supplement_1): 2512.

https://doi.org/10.1182/blood-2019-129280

Published: 2019

Journal Articles

MN1 Expression Is an Indepedent Prognostic Marker in FLT3-Mutated Acute Myeloid Leukemia and Is Involved in the Resistance to FLT3 Inhibitors

Diego A Pereira-Martins, MSc, Juan L Coelho-Silva, BSc, MSc, Isabel Weinhäuser, MSc, Carol Hassibe Thomé, César Alexander Ortiz Rojas, BSc, Luíse A A Simões, BSc, Fabiola Traina, MD PhD, Michael Heuser, MD, Arnold Ganser, MD, Antonio R. Lucena-Araujo, PhD, Eduardo M Rego, MD PhD

Blood (2019) 134 (Supplement_1): 1403.

https://doi.org/10.1182/blood-2019-131542

Published: 2019

Journal Articles

Menin Is a Therapeutic Target in MN1 High Leukemia

Clara Libbrecht, MD, Simone Stefanie Riedel, PhD, Jessica Haladyna, BA,MS, Kathrin M. Bernt, MD

Blood (2018) 132 (Supplement 1): 758.

https://doi.org/10.1182/blood-2018-99-115551

Published: 2018

Journal Articles

Coagulation Activation in Brain Neoplasms

Swaroopa Yerrabothala, MD, Brett L. Gourley, MD, James C Ford, PhD, Syed Rakin Ahmed, Stephen J Guerin, MD, Heather A Wishart, PhD, Camilo E Fadul, MD, Deborah L. Ornstein, MD

Blood (2017) 130 (Supplement 1): 3704.

https://doi.org/10.1182/blood.V130.Suppl_1.3704.3704

Published: 2017

Journal Articles

Prophylactic CNS Therapy (with or without Radiation Therapy) in Medium-High Risk Acute Lymphoblastic Leukemia (ALL) Children: Long-Term Outcome Evaluation of the Randomized BFM-Oriented Trial 58832 (period 1983-1989) of the EORTC Children Leukemia Group

Blood (2016) 128 (22): 2775.

https://doi.org/10.1182/blood.V128.22.2775.2775

Published: 2016

Journal Articles

Incidence of Malignancies in Gaucher's Disease Patients. Data of Spanish Gaucher's Disease Registry

Marcio Andrade-Campos, MD PhD, Abelardo Barez, Soledad Noya, M Angeles Fernández-Galán, Jose Balanzat, MD, F García-Bragado, Angela Ibañez, Pilar Giraldo, MD PhD

Blood (2016) 128 (22): 4881.

https://doi.org/10.1182/blood.V128.22.4881.4881

Published: 2016

Journal Articles

Phenotype Analysis and Clinical Management in a Large Family with a Novel Truncating Mutation in RASGRP2 , the Caldag-GEFI Encoding Gene

Amrita Desai, MD MPH, Wenche Jy, PhD, Wolfgang Bergmeier, PhD, Mathias Canault, PhD, Marie-Christine Alessi, MD PhD, Paquita Nurden, MD PhD, Yeon-Soong Ahn, MD, Alan T. Nurden, PhD

Blood (2016) 128 (22): 3713.

https://doi.org/10.1182/blood.V128.22.3713.3713

Published: 2016

Journal Articles

Meningeoma-1 Cooperates with MLL and DOT1L to Induce Leukemia

Simone Riedel, PhD, Jessica Haladyna, BA, Brett Stevens, Craig T Jordan, PhD, Daniel Pollyea, MD MS, Scott A. Armstrong, MD PhD, Qi Wei, PhD, Patricia Ernst, PhD, Tobias Neff, MD, Kathrin M Bernt, MD

Blood (2015) 126 (23): 2428.

https://doi.org/10.1182/blood.V126.23.2428.2428

Published: 2015

Journal Articles

Front-Line Treatment with Ofatumumab for Older Unfit Patients with Chronic Lymphocytic Leukemia

Candida Vitale, MD, Maria Ciccone, MD, Christina Hinojosa, Michael Keating, MBBS, Naveen Pemmaraju, MD, Susan O'Brien, MD, William Wierda, MD PhD, Deborah A Thomas, MD, Gautam Borthakur, MD, Maro Ohanian, DO, Jan A. Burger, MD PhD, Alessandra Ferrajoli, MD

Blood (2015) 126 (23): 5292.

https://doi.org/10.1182/blood.V126.23.5292.5292

Published: 2015

Journal Articles

Elevation of Plasma α-Synuclein Levels Is Diagnostic of Malignant or Invasive Central Nervous System Neoplasms

Catherine M Stefaniuk, DO, Quinn Ostrom, MA MPH, Jill Barnholtz-Sloan, PhD, Joseph Willis, MD, Robert W. Maitta, MDPhD

Blood (2015) 126 (23): 5597.

https://doi.org/10.1182/blood.V126.23.5597.5597

Published: 2015

Journal Articles

Clinical Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Central Nervous System Involvement: An International Multicenter Collaboration

Chan Yoon Cheah, MBBS DMedSc, Paul J Broeckelmann, MD, Alison J Moskowitz, MD, Andreas Engert, MD, Mats Jerkeman, MD PhD, Tarec Christoffer El-Galaly, Julie Vose, Diego Villa, MDMPH, Joseph M. Connors, MD, Tatyana Feldman, MD, Dai Chihara, MD PhD, Chelsea C Pinnix, MDPhD, Sarah A Milgrom, MD, Bouthaina S. Dabaja, MD, Yasuhiro Oki, MD, Michelle A. Fanale, MD

Blood (2015) 126 (23): 3865.

https://doi.org/10.1182/blood.V126.23.3865.3865

Published: 2015

Journal Articles

Early Results of a Phase II Study of Ofatumumab As Front-Line Treatment in Elderly, Unfit Patients with Chronic Lymphocytic Leukemia (CLL)

Maria Ciccone, MD, Candida Vitale, Christina Hinojosa, Michael J Keating, MBBS, Naveen Pemmaraju, MD, Susan O'Brien, MD, Jan A. Burger, MD PhD, Deborah A. Thomas, MD, Hagop M. Kantarjian, MD, Paolo Strati, MD, William G. Wierda, MD PhD, Alessandra Ferrajoli, MD

Blood (2014) 124 (21): 5656.

https://doi.org/10.1182/blood.V124.21.5656.5656

Published: 2014

Journal Articles

ABR, a Novel Inducer Of Transcription Factor C/EBPα, Is Necessary For Myeloid Differentiation and a Prognostic Factor In Acute Myeloid Leukemia

Carolina Yaeko Namasu, MSc, Dennis Gerloff, Alexander Arthur Wurm, Daniela Braeuer-Hartmann, Jens-Uwe Hartmann, Christiane Katzerke, Sebastian Schwind, MD, Nadja Hilger, Stephan Fricke, MD, Dietger Niederwieser, MD, Gerhard Behre, MD

Blood (2013) 122 (21): 3814.

https://doi.org/10.1182/blood.V122.21.3814.3814

Published: 2013

Journal Articles

Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

Blood (2012) 120 (21): 661.

https://doi.org/10.1182/blood.V120.21.661.661

Published: 2012

Journal Articles

Anaplastic Lymphoma Kinase (ALK)-Positive Diffuse Large B-Cell Lymphoma Presenting with CNS Involvement: A Case Report

Blakely D Kute, MD, Aaron Spalding, MD, PhD, Alvin W. Martin, MD, David Sun, MD, PhD

Blood (2011) 118 (21): 5225.

https://doi.org/10.1182/blood.V118.21.5225.5225

Published: 2011

Journal Articles

Analysis of Second Primary Malignancies in Lenalidomide-Treated Patients with IPSS Low- or Int-1-Risk Myelodysplastic Syndromes

Aristoteles Giagounidis, MD, Azra Raza, MD, Alan F. List, MD, Pierre Fenaux, MD, PhD, Bouchra Benettaib, MD, Benton Brown, MD, Jim Zhong, PhD, Nancy Brandenburg, PhD, Ghulam J. Mufti, MD

Blood (2011) 118 (21): 1704.

https://doi.org/10.1182/blood.V118.21.1704.1704

Published: 2011

Journal Articles

Over Expression of MN1 Confers Resistance to Chemotherapy In Vitro and In Vivo

Timothy Pardee, MD, PhD, Teresa Mascenik, BA, Britt H. Bolemon, MD, Guerry J Cook, MSc

Blood (2010) 116 (21): 969.

https://doi.org/10.1182/blood.V116.21.969.969

Published: 2010

Journal Articles

Competition In Engraftment of Normal Hematopoietic Stem Cells and Leukemic Stem Cells

Gyeongsin Park, Michael Heuser, Tobias Berg, MD, R. Keith Humphries

Blood (2010) 116 (21): 4836.

https://doi.org/10.1182/blood.V116.21.4836.4836

Published: 2010

Journal Articles

Patients with Polycythemia Vera and Essential Thrombocytosis Have a Higher Risk of Prior or Concurrent Tumors Compared to Patients with Secondary Thrombocytosis

Krisstina Gowin, D.O., Caroline Irene Piatek, M.D., Siamak Saadat, M.D., Karren Cuadra, Pedram Razavi, M.D., Ph.D., Ronald Tang, MD, Casey L. O'Connell, MD

Blood (2010) 116 (21): 3084.

https://doi.org/10.1182/blood.V116.21.3084.3084

Published: 2010

NARROW

Myeloid Neoplasms with t(12;22)(p13;q12) and MN1 Ectopia Are Refractory to Chemotherapy and Can Benefit from Hematopoietic Stem Cell Transplantation

SWI/SNF Dysregulation through a Prion-like Domain Causes AML

MN1 Expression Is an Indepedent Prognostic Marker in FLT3-Mutated Acute Myeloid Leukemia and Is Involved in the Resistance to FLT3 Inhibitors

Menin Is a Therapeutic Target in MN1 High Leukemia

Coagulation Activation in Brain Neoplasms

Prophylactic CNS Therapy (with or without Radiation Therapy) in Medium-High Risk Acute Lymphoblastic Leukemia (ALL) Children: Long-Term Outcome Evaluation of the Randomized BFM-Oriented Trial 58832 (period 1983-1989) of the EORTC Children Leukemia Group

Incidence of Malignancies in Gaucher's Disease Patients. Data of Spanish Gaucher's Disease Registry

Phenotype Analysis and Clinical Management in a Large Family with a Novel Truncating Mutation in RASGRP2 , the Caldag-GEFI Encoding Gene

Meningeoma-1 Cooperates with MLL and DOT1L to Induce Leukemia

Front-Line Treatment with Ofatumumab for Older Unfit Patients with Chronic Lymphocytic Leukemia

Elevation of Plasma α-Synuclein Levels Is Diagnostic of Malignant or Invasive Central Nervous System Neoplasms

Clinical Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Central Nervous System Involvement: An International Multicenter Collaboration

Early Results of a Phase II Study of Ofatumumab As Front-Line Treatment in Elderly, Unfit Patients with Chronic Lymphocytic Leukemia (CLL)

ABR, a Novel Inducer Of Transcription Factor C/EBPα, Is Necessary For Myeloid Differentiation and a Prognostic Factor In Acute Myeloid Leukemia

Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

Anaplastic Lymphoma Kinase (ALK)-Positive Diffuse Large B-Cell Lymphoma Presenting with CNS Involvement: A Case Report

Analysis of Second Primary Malignancies in Lenalidomide-Treated Patients with IPSS Low- or Int-1-Risk Myelodysplastic Syndromes

Over Expression of MN1 Confers Resistance to Chemotherapy In Vitro and In Vivo

Competition In Engraftment of Normal Hematopoietic Stem Cells and Leukemic Stem Cells

Patients with Polycythemia Vera and Essential Thrombocytosis Have a Higher Risk of Prior or Concurrent Tumors Compared to Patients with Secondary Thrombocytosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only